In rare cases, severe dehydration associated with GLP-1 use has been linked to acute kidney injury
Personal dosing (also known as microdosing) is when you use lower doses than the standard protocols approved by the FDA
The mechanisms behind this increased risk are multifactorial: Iron and Estrogen Synergy: In breast tissue, iron synergizes with estrogen metabolites to generate reactive species, a process intensified in post-menopause when iron stores rise
Prolonged continuous use without an off period raises a theoretical risk of copper accumulation
Acids can dismantle the copper-peptide bond and prevent absorption
Manufacturing & Quality Assurance This product is manufactured under cGMP (current Good Manufacturing Practice) standards, which means the facility, equipment, personnel, and processes meet strict FDA regulatory requirements